Improving the diagnosis of Alzheimer’s disease thanks to European research collaboration

Brussels, Belgium

5 December 2017
12:30 – 14:00
European Parliament, Room JAN4Q2

60 Rue Wiertz, 1047 Brussels, Belgium




Heinz K. Becker, MEP, Member of the European Alzheimer’s Alliance


Diagnosing Alzheimer’s disease and Alzheimer’s dementia: A paradigm shift thanks to biomarkers

Prof. Philip Scheltens, VUMC Amsterdam, Netherlands


Promoting the timely diagnosis of neurocognitive disorders: Lessons from the European Joint Action on Dementia

Prof. Pierre Krolak-Salmon, Institut du Vieillissement, Lyon, France


Supporting clinicians in making a diagnosis: The PredictND clinical decision support tool

Dr Jyrki Lötjönen, Combinostics, Helsinki, Finland


The AD portfolio of the Innovative Medicines Initiative and its AMYPAD and MOPEAD projects

Dr Elisabetta Vaudano, Innovative Medicines Initiative


Closing remarks

Olga Sehnalová, MEP, Member of the European Alzheimer’s Alliance


For more information, please contact: